UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors

Journal of general internal medicine : JGIM, 2022-05, Vol.37 (7), p.1603-1609

2022

Link zum Volltext

Verfügbarkeit prüfen

An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (7), p.1681-1688

2023

Link zum Volltext

Verfügbarkeit prüfen

Burden of influenza hospitalization among high-risk groups in the United States

BMC health services research, 2022-09, Vol.22 (1), p.1-1209, Article 1209

2022

Link zum Volltext

Verfügbarkeit prüfen

Physician patient sharing relationships within insurance plan networks

Health services research, 2023-10, Vol.58 (5), p.1056-1065

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world users of triple therapy for asthma in the US

The American journal of managed care, 2024-02, Vol.30 (2), p.74-81

2024

Link zum Volltext

Verfügbarkeit prüfen

An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations

Journal of general internal medicine : JGIM, 2020-06, Vol.35 (6), p.1768-1775

2020

Link zum Volltext

Verfügbarkeit prüfen

Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

PharmacoEconomics, 2020-10, Vol.38 (10), p.1115-1121

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of intensification with SGLT2 inhibitors for type 2 diabetes

The American journal of managed care, 2021-08, Vol.27 (8), p.e269-e277

2021

Link zum Volltext

Verfügbarkeit prüfen

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

PharmacoEconomics, 2021-03, Vol.39 (3), p.317-330

2021

Link zum Volltext

Verfügbarkeit prüfen

Drug landscape in patients receiving general outpatient palliative care in Germany: results from a retrospective analysis of 10,464 patients

BMC palliative care, 2023-08, Vol.22 (1), p.1-118, Article 118

2023

Link zum Volltext

Verfügbarkeit prüfen

What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France

Applied health economics and health policy, 2023-09, Vol.21 (5), p.799-811

2023

Link zum Volltext

Verfügbarkeit prüfen

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy

Therapeutics and clinical risk management, 2021-01, Vol.17, p.345-356

2021

Link zum Volltext

Verfügbarkeit prüfen

Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs

BMC health services research, 2020-08, Vol.20 (1), p.803-803, Article 803

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China

Cost effectiveness and resource allocation, 2021-08, Vol.19 (1), p.1-46, Article 46

2021

Link zum Volltext

Verfügbarkeit prüfen

Cystitis and Utipro ® Plus: Real-World Evidence

Healthcare (Basel), 2023-09, Vol.11 (18), p.2564

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

ClinicoEconomics and outcomes research, 2023-01, Vol.15, p.87-96

2023

Link zum Volltext

Verfügbarkeit prüfen

Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era

Journal of personalized medicine, 2023-05, Vol.13 (5), p.833

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

The patient : patient-centered outcomes research, 2022-11, Vol.15 (6), p.703-713

2022

Link zum Volltext

Verfügbarkeit prüfen

Dysbiosis: A Potential Precursor to the Development of a Depressive Disorder

Healthcare (Basel), 2022-08, Vol.10 (8), p.1503

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Spirometry Testing among Patients with Asthma and COPD in German General Practices

Healthcare (Basel), 2022-12, Vol.10 (12), p.2570

2022

Link zum Volltext

Verfügbarkeit prüfen

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico

PharmacoEconomics - open, 2023-09, Vol.7 (5), p.841-849

2023

Link zum Volltext

Verfügbarkeit prüfen

High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

PharmacoEconomics - open, 2021-09, Vol.5 (3), p.385-396

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis

ClinicoEconomics and outcomes research, 2022-01, Vol.14, p.691-697

2022

Link zum Volltext

Verfügbarkeit prüfen

Health Care Resource Utilization in Adults Living With Type 1 Diabetes Mellitus in the South African Public Health Sector: Protocol for a 1-Year Retrospective Analysis With a 5-, 10-, and 25-Year Projection

JMIR research protocols, 2023-02, Vol.12, p.e44308-e44308

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 198

Suche als RSS-Feed

Aktive Filter

ThemaHealth Care Sciences & Services

ThemaPatients

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(198)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(198)
Health Policy & Services
(104)
Humans
(92)
Medicine
(62)
Medicine & Public Health
(52)
Public Health
(46)
Diabetes
(41)
Health Care
(41)
Physicians
(38)
Primary Care
(37)
Health Care Policy
(34)
Pharmacoeconomics And Health Outcomes
(33)
Health Economics
(32)
Health Administration
(31)
General & Internal Medicine
(30)
Medical Informatics
(30)
Social Sciences
(30)

12 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors

An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

Burden of influenza hospitalization among high-risk groups in the United States

Physician patient sharing relationships within insurance plan networks

Real-world users of triple therapy for asthma in the US

An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations

Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

Cost-effectiveness of intensification with SGLT2 inhibitors for type 2 diabetes

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

Drug landscape in patients receiving general outpatient palliative care in Germany: results from a retrospective analysis of 10,464 patients

What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy

Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China

Cystitis and Utipro ® Plus: Real-World Evidence

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Dysbiosis: A Potential Precursor to the Development of a Depressive Disorder

Prevalence of Spirometry Testing among Patients with Asthma and COPD in German General Practices

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico

High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis

Health Care Resource Utilization in Adults Living With Type 1 Diabetes Mellitus in the South African Public Health Sector: Protocol for a 1-Year Retrospective Analysis With a 5-, 10-, and 25-Year Projection

Aktive Filter

Suchergebnisse filtern